• Richard Francis, CEO Sandoz, to step down on March 31, 2019
  • Francesco Balestrieri, Head Region Europe, Sandoz, appointed ad-interim CEO Sandoz

Basel, March 14, 2019 – Novartis announced today that Richard Francis will be stepping down as CEO of Sandoz, a Novartis division, and as a member of the Executive Committee of Novartis on March 31, 2019. Francesco Balestrieri, currently Region Head Europe, Sandoz, has been appointed ad-interim CEO Sandoz. He will report to Vas Narasimhan, CEO, Novartis.

Vas Narasimhan said; “I would …

  • Sandoz commits to increasing support from one winner to three, following impressive pitches from the finalists
  • Winning ideas proposed innovative uses of artificial intelligence, mobile apps and digital therapeutics to address healthcare access challenges
  • Sandoz invited people worldwide to “reimagine access to healthcare” by identifying practical, scalable digital solutions to address unmet medical needs

Austin, Texas, March 10, 2019 Sandoz, a Novartis division, today announced the winners of the 2019 Sandoz …